Corner Therapeutics
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $54M
Overview
Creating targeted immunotherapies for oncology and autoimmune disorders.
OncologyImmunology
Technology Platform
A platform for developing targeted immunomodulators designed to precisely activate or suppress specific immune pathways.
Funding History
1Total raised:$54M
Series A$54M
Opportunities
A precisely targeted therapy could achieve superior efficacy and safety, capturing significant market share in large indications.
Risk Factors
Risk of failing to demonstrate meaningful clinical advantage over existing, often cheaper, immunomodulatory drugs.
Competitive Landscape
Enters crowded fields in both immuno-oncology and autoimmune disease, requiring clear differentiation from existing therapies.